TY - JOUR
T1 - Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization
AU - Allsopp, Catherine E.M.
AU - Plebanski, Magdalena
AU - Gilbert, Sarah
AU - Sinden, Robert E.
AU - Harris, Steve
AU - Frankel, Gadi
AU - Dougan, Gordon
AU - Hioe, Catarina
AU - Nixon, Douglas
AU - Paoletti, Enzo
AU - Lajton, Guy
AU - Hill, Adrian V.S.
PY - 1996
Y1 - 1996
N2 - A variety of vaccine delivery systems including peptides with various adjuvants, recombinant particles, live recombinant viruses and bacteria and plasmid DNA were tested for their ability to induce CD8+ cytotoxic T lymphocytes (CTL) against a well-defined epitope (amino acids 252-260) from the circumsporozoite (CS) protein of Plasmonium berghei. We compared routes of immunization that would be applicable for the administration of a malaria vaccine in humans. The majority of these vaccines did not induce high CTL responses in the spleens of immunized mice. However, both a yeast-derived Ty virus like particle expressing the optimal nine-amino acid epitope SYIPSAEKI from the CS protein (CSP-VLP) and a lipid-tailed peptide of this same sequence induced high levels of the major histocompatibility complex (MHC) class I-restricted CTL with one and three subcutaneous immunizations, respectively. Moreover, these CTL were able to recognize naturally processed antigen expressed by a recombinant vaccinia virus. The levels of CTL induced by CSP-VLP could be augmented by coimmunization with certain cytokines. Target cells pulsed with CSP-VLP were recognized and lysed, showing that the particles were effectively processed and presented through MHC class I presentation pathway. The levels of CTL induced using CSP-VLP and lipopeptides are comparable to those observed after immunization with multiple doses of irradiated sporozoites.
AB - A variety of vaccine delivery systems including peptides with various adjuvants, recombinant particles, live recombinant viruses and bacteria and plasmid DNA were tested for their ability to induce CD8+ cytotoxic T lymphocytes (CTL) against a well-defined epitope (amino acids 252-260) from the circumsporozoite (CS) protein of Plasmonium berghei. We compared routes of immunization that would be applicable for the administration of a malaria vaccine in humans. The majority of these vaccines did not induce high CTL responses in the spleens of immunized mice. However, both a yeast-derived Ty virus like particle expressing the optimal nine-amino acid epitope SYIPSAEKI from the CS protein (CSP-VLP) and a lipid-tailed peptide of this same sequence induced high levels of the major histocompatibility complex (MHC) class I-restricted CTL with one and three subcutaneous immunizations, respectively. Moreover, these CTL were able to recognize naturally processed antigen expressed by a recombinant vaccinia virus. The levels of CTL induced by CSP-VLP could be augmented by coimmunization with certain cytokines. Target cells pulsed with CSP-VLP were recognized and lysed, showing that the particles were effectively processed and presented through MHC class I presentation pathway. The levels of CTL induced using CSP-VLP and lipopeptides are comparable to those observed after immunization with multiple doses of irradiated sporozoites.
KW - Cytotoxic T lymphocyte
KW - Malaria
KW - Plasmodium berghei
KW - Vaccine
UR - http://www.scopus.com/inward/record.url?scp=9444289849&partnerID=8YFLogxK
U2 - 10.1002/eji.1830260841
DO - 10.1002/eji.1830260841
M3 - Article
C2 - 8765044
AN - SCOPUS:9444289849
SN - 0014-2980
VL - 26
SP - 1951
EP - 1959
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 8
ER -